An interventional study of Dry Needling and Extracorporeal Shock Wave Therapy in Myofascial Pain Syndrome, sponsored by ALİEMAN. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-05-07.
Sponsored by ALİEMAN · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 81 studies in Myofascial Pain Syndromes with a site in Turkey — 12 open to participants now, 12 under way, none of them phase 3. Myofascial Pain Syndromes · Turkey.
Among the 81 studies in Myofascial Pain Syndromes with a site in Turkey, this one is the 24th largest by planned enrollment of the 67 interventional ones that give a count, is one of 8 that started in 2026, is one of 62 with no phase, reaches primary completion later than 9 of the 11 other live ones, and was the 70th registered.
340 studies on the registry are indexed under Myofascial Pain Syndromes; 67 are open to participants now.
Browse Myofascial Pain Syndromes studies →12 of the 81 studies in Myofascial Pain Syndromes with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University · Sites in Turkey
Ages 18–55
Ankara Etlik City Hospital · Sites in Turkey
Ages 18–65
Ankara University · Sites in Turkey
Ages 18–65
Gazi University · Sites in Turkey
Ages 18–35 · Women only
Firat University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 35 Myofascial Pain Syndromes studies recruiting now, 6 (17%) set no upper age limit and 26 (74%) stop at 75 or younger; 2 take children under 18; 4 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
81 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is above the median of 51 across 308 interventional studies indexed under Myofascial Pain Syndromes.
Median enrollment 60 across the 67 interventional studies, 110 across the 14 observational. Of the 64 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 81 have an industry lead sponsor. The 10 most frequent:
ALİEMAN is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
ALİEMAN has 1 study filed under Myofascial Pain Syndromes — fewer than ten, so there is no comparison to draw.
3 of the studies in Myofascial Pain Syndromes with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07926113Medipol UniversityComparison of 26G and 30G Needles for Masseter Trigger Point Injections in Patients With Myofascial Pain Syndrome | 2027-01 |
| NCT07511751ALİEMANCOMPARISON OF THREE TREATMENT MODALITIES IN MYOFASCIAL PAIN SYNDROME | 2027-03-10 |
| NCT07904364Mardin Artuklu UniversityAgreement Between CSI and IASP Pain Classification in Chronic Cervical Myofascial Pain | 2027-06-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 81 studies in Myofascial Pain Syndromes with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to compare the effectiveness of dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) in patients with chronic musculoskeletal pain. The primary outcomes include pain intensity and functional status. Patients will be randomly assigned to different treatment groups, and outcomes will be evaluated before and after the interventions. The results of this study are expected to contribute to determining the most effective treatment method for pain management.
Myofascial pain syndrome is a common musculoskeletal disorder characterized by trigger points and chronic pain. Various treatment modalities such as dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) are used in clinical practice; however, there is no clear consensus on the most effective approach.
This randomized, parallel-group study aims to compare the effectiveness of these three treatment methods in patients diagnosed with myofascial pain syndrome. Eligible patients aged between 18 and 65 years with chronic back pain lasting at least 3 months will be included in the study. Participants will be randomly assigned to receive dry needling, ESWT, or PRF treatment.
Pain intensity will be assessed using the Numeric Rating Scale (NRS), and functional outcomes will also be evaluated. The study is expected to contribute to the current literature by providing comparative data on these commonly used treatment modalities and guiding clinical decision-making.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients receiving dry needling treatment.
Procedure: Dry Needling
Patients receiving extracorporeal shock wave therapy (ESWT)
Procedure: Extracorporeal Shock Wave Therapy
Patients receiving pulsed radiofrequency (PRF) treatment.
Procedure: Pulsed radiofrequency(PRF)
Dry needling applied to myofascial trigger points
Extracorporeal shock wave therapy applied to the painful area
Pulsed radiofrequency applied to the target area for the treatment of myofascial pain syndrome
Pain Intensity
Pain intensity will be assessed using the Numeric Rating Scale(NRS). Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.
Time frame: Baseline, 1 month, and 3 months after treatment
Pressure Pain Threshold
Pressure pain threshold will be measured using algometry. Pressure pain threshold will be measured using an algometer (kg/cm²). Higher values indicate lower pain sensitivity and improved clinical condition.
Time frame: Baseline, 1 month, and 3 months after treatment
Neck Disability Index (NDI)
Functional status will be evaluated using the Neck Disability Index (NDI). Functional status will be assessed using the Neck Disability Index (NDI), with scores ranging from 0 to 50. Higher scores indicate greater functional impairment.
Time frame: Baseline, 1 month, and 3 months after treatment
Quality of Life (SF-12
Quality of life will be assessed using the Short Form-12 (SF-12) questionnaire. The SF-12 includes physical and mental component summary scores, with higher scores indicating better health-related quality of life.
Time frame: Baseline, 1 month, and 3 months after treatment
Plan to share: No
No publications or documents are linked to this record.
Started Mar 2026 (actual). Primary completion is estimated for Mar 2027, 12 months after the start.
Of 203 non-industry interventional studies with no phase under Myofascial Pain Syndromes, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 13. This study's planned 12 months is above that.
Counting every sponsor, half of 205 studies reached it within 5 months; a quarter within 2 and three quarters within 13.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.